WASHINGTON, Dec. 13, 2012 /PRNewswire/ -- Galileo Analytics announced today that the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer, has selected the Galileo Cosmos™ platform to serve as an analytic component of the CancerLinQ™ prototype, the first phase of the society's multi-phase effort to build a "rapid-learning system" in cancer care.
Galileo will provide real-time visual data mining and advanced analytics within the de-identified data of the breast cancer-specific prototype. The ability to visually explore complex data and perform sophisticated analytics in real-time is at the essence of CancerLinQ.
ASCO's vision for CancerLinQ is a comprehensive, knowledge-generating computer network, which will pull in data from a variety of sources and make that data accessible and understandable to health care providers, researchers and patients. Through CancerLinQ, ASCO seeks to speed the generation of new knowledge and understanding, so the cancer community can learn from all patients, not just the small percentage who participate in clinical trials.
The development of the prototype will allow ASCO to determine and overcome technological barriers to creating a more robust system encompassing all types of cancer, as well as identify requirements around the use of data standards.
"We are honored to be a part of the development of the CancerLinQ prototype," said Simon Fitall, CEO, Galileo Analytics. "We designed Galileo Cosmos to enable the rapid exploration of the most complex health data available. Our vision is to move data research out of the computer lab and into the hands of physicians, researchers and caregivers, giving them the power to find the meaningful connections that will improve care. CancerLinQ embodies that vision, and we're thrilled to be part of making it a reali
|SOURCE Galileo Analytics|
Copyright©2012 PR Newswire.
All rights reserved